Inventiva S.A. (IVA) reporting calendar
Inventiva S.A. files periodic reports with the SEC as IVA on Nasdaq. Atlas tracks 6 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 20-F
- Period ended
- 31 Dec 2025
- Filed
- 8 Apr 2026
- Reports on record
- 6
Open IVA market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Dec 2025 | 8 Apr 2026 | 98 days | 0001104659-26-040704 |
| 20-F | 31 Dec 2024 | 15 Apr 2025 | 105 days | 0001104659-25-035122 |
| 20-F | 31 Dec 2023 | 3 Apr 2024 | 94 days | 0001104659-24-042817 |
| 20-F | 31 Dec 2022 | 30 Mar 2023 | 89 days | 0001104659-23-038571 |
| 20-F | 31 Dec 2021 | 11 Mar 2022 | 70 days | 0001104659-22-032953 |
| 20-F | 31 Dec 2020 | 15 Mar 2021 | 74 days | 0001171843-21-001782 |
Source: SEC EDGAR company submissions for CIK 0001756594. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.